The pharmaceutical industry leader Aragen Life Sciences has revealed grand aspirations to grow its business in Hyderabad, India. With this development, the company hopes to invest an astounding ₹2,000 crore, which should result in the creation of almost 1,500 new jobs.The main objective of this growth is to improve the company’s medication discovery, development, and manufacturing capabilities while keeping a close eye on the needs of the global life sciences industry. Following a fruitful meeting between Telangana Chief Minister A Revanth Reddy and Manni Kantipudi, the permanent director and CEO of Aragen Life Sciences, on the fringes of the World Economic Forum’s annual meeting in Davos, the decision to embark on this momentous investment journey was made public.
Chief Minister Reddy expressed his happiness by saying, “I am thrilled that Aragen Life Sciences, a leading pharmaceutical company worldwide, has selected significant investment plans in Hyderabad. This demonstrates the commitment of the new administration to creating a cutting-edge, dynamic ecosystem, amazing infrastructure, and a wealth of talent that can spur innovation.”
Kantipudi expressed the company’s enthusiasm for its five-year expansion plan, echoing Reddy’s views. “We are excited about our five-year expansion plans and have decided to invest ₹2,000 crore in Hyderabad, Telangana,” Kantipudi said. In addition, he praised Chief Minister Reddy’s leadership and expressed hope that Hyderabad will continue to establish itself as a leading national center for CDMOs and CROs (contract research organizations) in the years to come.
There is no denying Hyderabad’s allure as a key location for this expansion. The city has a lot going for it, including cutting-edge scientific expertise nearby, a strong supplier network, and an environment that encourages innovation in digital technology. Interestingly, Hyderabad is today home to more than 1,000 global innovators working on ground-breaking R&D projects involving novel medications and medical gadgets.
With over 20 years of experience, Aragen Life Sciences is a leading provider of contract research, development, and manufacturing services across the whole drug development life cycle. The company’s primary objective is to find and develop New Molecular Entities (NMEs) at an early stage, which positions it as a major force behind innovation and progress in the pharmaceutical industry.
The company wants to use its own experience and Hyderabad’s supportive ecosystem to spur growth and innovation in the life sciences industry as it sets out on this revolutionary expansion adventure. Aragen Life Sciences is positioned to have a big impact on the local and international pharmaceutical scene thanks to its large investment and dedication to generating new job opportunities.
